Comparison of In-Patient Costs for Children Treated on the AAML0531 Clinical Trial: A Report From the Children’s Oncology Group

BACKGROUND: A better understanding of drivers of treatment costs may help identify effective cost containment strategies and prioritize resources. We aimed to develop a method for estimating inpatient costs for pediatric patients with acute myeloid leukemia (AML) enrolled on NCI-funded Phase III tri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Blood Cancer
Autores principales: Getz, Kelly D., Li, Yimei, Alonzo, Todd A., Hall, Matthew, Gerbing, Robert B., Sung, Lillian, Huang, Yuan-Shung, Arnold, Staci, Seif, Alix E., Miller, Tamara P., Bagatell, Rochelle, Fisher, Brian T., Adamson, Peter C., Gamis, Alan, Keren, Ron, Aplenc, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4546551/
https://ncbi.nlm.nih.gov/pubmed/25946708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25569
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares